الصفحة الرئيسية>>Signaling Pathways>> GPCR/G protein>> Glucocorticoid Receptor>>Clobetasol propionate

Clobetasol propionate (Synonyms: CCl-4725, CGP 9555, Clobetasol 17-Propionate)

رقم الكتالوجGC11976

بروبيونات Clobetasol هو مثبط قوي وانتقائي CYP3A5 مع IC50 من 0.206 ميكرومتر

Products are for research use only. Not for human use. We do not sell to patients.

Clobetasol propionate التركيب الكيميائي

Cas No.: 25122-46-7

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
36٫00
متوفر
50mg
49٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Clobetasol propionate is a anti-inflammatory corticosteroid used to treat various skin disorders.Target: Glucocorticoid ReceptorClobetasol propionate is a corticosteroid of the glucocorticoid class used to treat various skin disorders including eczema and psoriasis. It is also highly effective for contact dermatitis caused by exposure to poison ivy/oak. Clobetasol belongs to US Class I (Europe: class IV) of the corticosteroids, making it one of the most potent available. It comes in shampoo, mousse, ointment and emollient cream presentations. It has very high potency and typically should not be used with occlusive dressings, or for extended continuous use (beyond two weeks). It is also used to treat several auto-immune diseases including alopecia areata, vitiligo and lichen planus (auto immune skin nodules). From Wikipedia.

References:
[1]. http://en.wikipedia.org/wiki/Clobetasol_propionate

مراجعات

Review for Clobetasol propionate

Average Rating: 5 ★★★★★ (Based on Reviews and 7 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Clobetasol propionate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.